BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Immunocytochemistry Assay, P16/Ki-67

    PMA: P190024 · Supplement: S013 · Decision Apr 25, 2025
    View on FDA
    Classifications
    1
    FEI Numbers
    1
    Registration Numbers
    1

    Basic Information

    Device Name
    Immunocytochemistry Assay, P16/Ki-67
    Trade Name
    CINtec PLUS Cytology
    PMA Number
    P190024
    Supplement Number
    S013
    Device Class
    FDA Class 3
    Product Code
    QKF
    Generic Name
    Immunocytochemistry assay, p16/Ki-67
    Regulation Number
    864.1860
    Medical Specialty
    Hematology
    Advisory Committee
    Pathology
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    April 25, 2025
    Date Received
    December 30, 2024
    Supplement Type
    Normal 180 Day Track
    Supplement Reason
    Change Design/Components/Specifications/Material
    Expedited Review
    N

    Advisory Committee Statement

    Approval for migration of the CINtec PLUS Cytology assay to a new automated slide stainer instrument, BenchMark ULTRA PLUS.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    QKF Immunocytochemistry Assay, P16/Ki-67